Tag: patent expiration
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Biosimilars are set to transform healthcare as major biologics like Keytruda and Eylea lose patent protection between 2025 and 2030. Learn how these complex, lower-cost alternatives are entering the market, what’s holding them back, and what it means for patients and providers.
read moreInternational Patent Expiration: How Deadlines Vary Around the World
Patent expiration varies globally due to extensions, maintenance fees, and local laws. A 20-year term isn't universal-delays, regulatory approvals, and missed payments can shorten or extend protection in different countries.
read more